Pigment epithelium‑derived factor protects human glomerular mesangial cells from diabetes via NOXO1‑iNOS suppression

Gao,Ling; Hu,Yingjie; Li,Jing

doi:10.3892/mmr.2017.7563

Pigment epithelium‑derived factor protects human glomerular mesangial cells from diabetes via NOXO1‑iNOS suppression

Authors:
- Ling Gao
- Yingjie Hu
- Jing Li
View Affiliations

Affiliations: Department of Endocrinology, Renmin Hospital of Wuhan University, Wuhan 430060, P.R. China
Published online on: September 20, 2017 https://doi.org/10.3892/mmr.2017.7563
Pages: 7855-7863

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The authors previously reported that pigment epithelium‑derived factor (PEDF) protects the diabetic kidney from fibrosis via its anti‑oxidative effects. However, the underlying molecular mechanism has never been revealed. The present study aimed to investigate how PEDF protects mesangial cells from diabetes induced damage. Human mesangial cells were exposed to a diabetic environment [30 mmol/l glucose and 200 mg advanced glycation end products (AGEs)] in the absence or presence of PEDF (200 mg/l). The superoxide and peroxynitrite productions were measured by fluorescent assay. The nicotinamide adenine dinucleotide phosphate (NAPDH) oxidases (NOXs; isoforms NOX1, NOX2, and NOX4), NADPH oxidase organizer 1 (NOXO1), DHFR, endothelial nitric oxide synthase (iNOS) and phospho‑p38MAPK (p‑p38) protein levels were also examined to explore the possible mechanism of the PEDF anti‑oxidative properties. The fibrogenesis of mesangial cells in diabetes was associated with increased superoxide generation and peroxynitrite production via iNOS induction and uncoupling. However, elevated transforming growth factor‑β level, reactive oxygen species (ROS) overproduction, iNOS induction and uncoupling were all reversed by NOXO1 suppression following PEDF treatment or NOXO1 silencing. Furthermore, the p38MAPK inhibition only attenuated the ROS/peroxynitrite production partially via abolishment of iNOS induction, however had no effect on iNOS uncoupling and its regulating enzyme: DHFR suppression. PEDF prevented oxidative stress and protected mesangial cells from fibrogenesis in a diabetic environment via dual effects mediated by NOXO1 inhibitory prevention of iNOS induction through p38MAPK inactivation and effects on iNOS coupling through DHFR restoration.

View Figures

View References

1	Lee HB, Yu MR, Yang Y, Jiang Z and Ha H: Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol. 14 8 Suppl 3:S241–S245. 2003. View Article : Google Scholar : PubMed/NCBI
2	Nishikawa T and Araki E: Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal. 9:343–353. 2007. View Article : Google Scholar : PubMed/NCBI
3	Forbes JM, Coughlan MT and Cooper ME: Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 57:1446–1454. 2008. View Article : Google Scholar : PubMed/NCBI
4	Giacco F and Brownlee M: Oxidative stress and diabetic complications. Circ Res. 107:1058–1070. 2010. View Article : Google Scholar : PubMed/NCBI
5	Sedeek M, Callera G, Montezano A, Gutsol A, Heitz F, Szyndralewiez C, Page P, Kennedy CR, Burns KD, Touyz RM and Hébert RL: Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: Implications in type 2 diabetic nephropathy. Am J Physiol Renal Physiol. 299:F1348–F1358. 2010. View Article : Google Scholar : PubMed/NCBI
6	Hancock JT, Desikan R and Neill SJ: Role of reactive oxygen species in cell signalling pathways. Biochem Soc Trans. 29:345–350. 2001. View Article : Google Scholar : PubMed/NCBI
7	Youn JY, Gao L and Cai H: The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes. Diabetologia. 55:2069–2079. 2012. View Article : Google Scholar : PubMed/NCBI
8	Jha JC, Thallas-Bonke V, Banal C, Gray SP, Chow BS, Ramm G, Quaggin SE, Cooper ME, Schmidt HH and Jandeleit-Dahm KA: Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy. Diabetologia. 59:379–389. 2016. View Article : Google Scholar : PubMed/NCBI
9	Lee DY, Wauquier F, Eid AA, Roman LJ, Ghosh-Choudhury G, Khazim K, Block K and Gorin Y: Nox4 NADPH oxidase mediates peroxynitrite-dependent uncoupling of endothelial nitric-oxide synthase and fibronectin expression in response to angiotensin II: Role of mitochondrial reactive oxygen species. J Biol Chem. 288:28668–28686. 2013. View Article : Google Scholar : PubMed/NCBI
10	Gorin Y, Cavaglieri RC, Khazim K, Lee DY, Bruno F, Thakur S, Fanti P, Szyndralewiez C, Barnes JL, Block K and Abboud HE: Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes. Am J Physiol Renal Physiol. 308:F1276–F1287. 2015. View Article : Google Scholar : PubMed/NCBI
11	Eid AA, Lee DY, Roman LJ, Khazim K and Gorin Y: Sestrin 2 and AMPK connect hyperglycemia to Nox4-dependent endothelial nitric oxide synthase uncoupling and matrix protein expression. Mol Cell Biol. 33:3439–3460. 2013. View Article : Google Scholar : PubMed/NCBI
12	Prabhakar S, Starnes J, Shi S, Lonis B and Tran R: Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production. J Am Soc Nephrol. 18:2945–2952. 2007. View Article : Google Scholar : PubMed/NCBI
13	Chen H, Zheng Z, Li R, Lu J, Bao Y, Ying X, Zeng R and Jia W: Urinary pigment epithelium-derived factor as a marker of diabetic nephropathy. Am J Nephrol. 32:47–56. 2010. View Article : Google Scholar : PubMed/NCBI
14	Wang JJ, Zhang SX, Mott R, Knapp RR, Cao W, Lau K and Ma JX: Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: Evidence for antifibrogenic activities. Diabetes. 55:1678–1685. 2006. View Article : Google Scholar : PubMed/NCBI
15	Tombran-Tink J, Chader GG and Johnson LV: PEDF: A pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res. 53:411–414. 1991. View Article : Google Scholar : PubMed/NCBI
16	Tombran-Tink J and Barnstable CJ: PEDF: A multifaceted neurotrophic factor. Nat Rev Neurosci. 4:628–636. 2003. View Article : Google Scholar : PubMed/NCBI
17	Becerra SP: Focus on molecules: Pigment epithelium-derived factor (PEDF). Exp Eye Res. 82:739–740. 2006. View Article : Google Scholar : PubMed/NCBI
18	Mao T, Gao L, Li H and Li J: Pigment epithelium-derived factor inhibits high glucose induced oxidative stress and fibrosis of cultured human glomerular mesangial cells. Saudi Med J. 32:769–777. 2011.PubMed/NCBI
19	Gao L, Pung YF, Zhang J, Chen P, Wang T, Li M, Meza M, Toro L and Cai H: Sepiapterin reductase regulation of endothelial tetrahydrobiopterin and nitric oxide bioavailability. Am J Physiol Heart Circ Physiol. 297:H331–H339. 2009. View Article : Google Scholar : PubMed/NCBI
20	Setsukinai K, Urano Y, Kakinuma K, Majima HJ and Nagano T: Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem. 278:3170–3175. 2003. View Article : Google Scholar : PubMed/NCBI
21	Sheikpranbabu S, Haribalaganesh R and Gurunathan S: Pigment epithelium-derived factor inhibits advanced glycation end-products-induced cytotoxicity in retinal pericytes. Diabetes Metab. 37:505–511. 2011.PubMed/NCBI
22	Gao L, Huang W and Li J: NOX1 abet mesangial fibrogenesis via iNOS induction in diabetes. Mol Cell Biochem. 382:185–191. 2013. View Article : Google Scholar : PubMed/NCBI
23	Cheng G and Lambeth JD: NOXO1, regulation of lipid binding, localization, and activation of Nox1 by the Phox homology (PX) domain. J Biol Chem. 279:4737–4742. 2004. View Article : Google Scholar : PubMed/NCBI
24	Li X, Liu W, Wang Q, Liu P, Deng Y, Lan T, Zhang X, Qiu B, Ning H and Huang H: Emodin suppresses cell proliferation and fibronectin expression via p38MAPK pathway in rat mesangial cells cultured under high glucose. Mol Cell Endocrinol. 307:157–162. 2009. View Article : Google Scholar : PubMed/NCBI
25	Ho C, Lee PH, Huang WJ, Hsu YC, Lin CL and Wang JY: Methylglyoxal-induced fibronectin gene expression through Ras-mediated NADPH oxidase activation in renal mesangial cells. Nephrology (Carlton). 12:348–356. 2007. View Article : Google Scholar : PubMed/NCBI
26	Liu CM, Qi XL, Yang YF and Zhang XD: Betulinic acid inhibits cell proliferation and fibronectin accumulation in rat glomerular mesangial cells cultured under high glucose condition. Biomed Pharmacother. 80:338–342. 2016. View Article : Google Scholar : PubMed/NCBI
27	Fang S, Jin Y, Zheng H, Yan J, Cui Y, Bi H, Jia H, Zhang H, Wang Y, Na L, et al: High glucose condition upregulated Txnip expression level in rat mesangial cells through ROS/MEK/MAPK pathway. Mol Cell Biochem. 347:175–182. 2011. View Article : Google Scholar : PubMed/NCBI
28	Yuan Z, Feng W, Hong J, Zheng Q, Shuai J and Ge Y: p38MAPK and ERK promote nitric oxide production in cultured human retinal pigmented epithelial cells induced by high concentration glucose. Nitric Oxide. 20:9–15. 2009. View Article : Google Scholar : PubMed/NCBI
29	Shatanawi A, Lemtalsi T, Yao L, Patel C, Caldwell RB and Caldwell RW: Angiotensin II limits NO production by upregulating arginase through a p38 MAPK-ATF-2 pathway. Eur J Pharmacol. 746:106–114. 2015. View Article : Google Scholar : PubMed/NCBI
30	Yang J, Duh EJ, Caldwell RB and Behzadian MA: Antipermeability function of PEDF involves blockade of the MAP kinase/GSK/beta-catenin signaling pathway and uPAR expression. Invest Ophthalmol Vis Sci. 51:3273–3280. 2010. View Article : Google Scholar : PubMed/NCBI
31	Gao S, Li C, Zhu Y, Wang Y, Sui A, Zhong Y, Xie B and Shen X: PEDF mediates pathological neovascularization by regulating macrophage recruitment and polarization in the mouse model of oxygen-induced retinopathy. Sci Rep. 7:428462017. View Article : Google Scholar : PubMed/NCBI
32	Wen H, Liu M, Liu Z, Yang X, Liu X, Ni M, Dong M, Luan X, Yuan Y, Xu X and Lu H: PEDF improves atherosclerotic plaque stability by inhibiting macrophage inflammation response. Int J Cardiol. 235:37–41. 2017. View Article : Google Scholar : PubMed/NCBI
33	Pacher P and Szabo C: Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am J Pathol. 173:2–13. 2008. View Article : Google Scholar : PubMed/NCBI
34	Kar S and Kavdia M: Endothelial NO and O₂⁻ production rates differentially regulate oxidative, nitroxidative, and nitrosative stress in the microcirculation. Free Radic Biol Med. 63:161–174. 2013. View Article : Google Scholar : PubMed/NCBI
35	Kouti L, Noroozian M, Akhondzadeh S, Abdollahi M, Javadi MR, Faramarzi MA, Mousavi S and Ghaeli P: Nitric oxide and peroxynitrite serum levels in Parkinson's disease: Correlation of oxidative stress and the severity of the disease. Eur Rev Med Pharmacol Sci. 17:964–970. 2013.PubMed/NCBI
36	Harrison DG, Chen W, Dikalov S and Li L: Regulation of endothelial cell tetrahydrobiopterin pathophysiological and therapeutic implications. Adv Pharmacol. 60:107–132. 2010. View Article : Google Scholar : PubMed/NCBI
37	Stern D, Yan SD, Yan SF and Schmidt AM: Receptor for advanced glycation endproducts: A multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev. 54:1615–1625. 2002. View Article : Google Scholar : PubMed/NCBI
38	Yamagishi S, Nakamura K, Matsui T, Noda Y and Imaizumi T: Receptor for advanced glycation end products (RAGE): A novel therapeutic target for diabetic vascular complication. Curr Pharm Des. 14:487–495. 2008. View Article : Google Scholar : PubMed/NCBI
39	Schröder K, Weissmann N and Brandes RP: Organizers and activators: Cytosolic Nox proteins impacting on vascular function. Free Radic Biol Med. 109:22–32. 2017. View Article : Google Scholar : PubMed/NCBI